Posttraumatic stress disorder (PTSD) is a deeply complex, often overlooked, and widely under researched condition – and we’re not shying away from it.
Roughly 6% of Americans will experience PTSD at some point in their lives, with veterans and women more likely to develop it. Awareness of PTSD has grown, but those who live with it still deserve better care and better treatment options.
Next year will mark the start of our Phase 3 Haven study to explore novel treatments for PTSD. For the millions suffering with the disorder, we hope this commitment brings hope.
To learn more about PTSD Awareness Month, please visit: https://t.co/IzsMYBaubj
#PTSD #MentalHealth #Neuroscience #HealthcareInnovation #DefiniumTherapeutics
The update you've all been waiting for...
His name is Jonah, and his Dream Day is July 12 at @loanDepotpark! Join us to cheer him on: https://t.co/chsJLKL3Si
Born in Aruba, Jonah is a rescued cunucu who found his forever home with the Silveira family thanks to New Life for Paws. Inspired by his story, each ticket sold through his link will have a portion of the proceeds donated to help local rescue dogs like Jonah.
The Miami Marlins are looking for the dog that went viral for watching another pup eat a hot dog during Monday’s game, promising the overlooked pooch a dream day at the ballpark.
The positive topline results from our Phase 3 Emerge clinical trial represent more than a company milestone, they reflect growing momentum toward potential new treatment possibilities for people living with major depressive disorder (MDD).
Hear from Emerge Principal Investigator and practicing clinical psychologist, John Sonnenberg, Ph.D., who shares his perspective on the significance of these findings and how the growing body of evidence surrounding psychedelics like pharmaceutical LSD is fueling excitement and optimism across the field of psychiatry.
Check out our recent press release to learn more about the Emerge Phase 3 topline data: https://t.co/MO7zkV9k02
#MentalHealth #DefiniumTherapeutics #Psychedelics #HealthcareInnovation #MDD #Depression
Milestone unlocked 🔓🔑. Today, we announced positive topline results from Emerge, the first Phase 3 study of our pharmaceutical LSD for major depressive disorder (MDD). These results mark a significant step forward in our mission to forge a new era of psychiatry, one with novel treatments that target underlying cause of disease, not just symptoms.
For patients who may have run out of options, these results matter. We’re energized by the momentum ahead as we continue pursuing potential new treatment options for the millions of people living with a mental health disorder. Learn more about this significant step: https://t.co/MO7zkV9k02
Una familia se reunió para ver el Mundial pero acabaron descubriendo que el abuelo tenía un montón de páginas porno guardadas en el televisor
JAJAJAJAJAJA